Grape King Bio (TPE:1707) Asset Turnover: 0.20 (As of Dec. 2025)


TPE:1707 Grape King Bio Ltd TPE:1707
79 GF Score
Price NT$91.60
GF Value NT$144.04
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Grape King Bio Asset Turnover?

Grape King Bio TPE:1707 +0.66% 79 Asset Turnover is 0.20 as of Dec. 2025. GuruFocus rates TPE:1707 with a GF Score™ of 79/100 and a GF Value™ of NT$144.04 (Possible Value Trap). The stock has 5 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Grape King Bio's Revenue for the three months ended in Dec. 2025 was NT$3,002 Mil. Grape King Bio's Total Assets for the quarter that ended in Dec. 2025 was NT$15,114 Mil. Therefore, Grape King Bio's Asset Turnover for the quarter that ended in Dec. 2025 was 0.20.

Asset Turnover is linked to ROE % through Du Pont Formula. Grape King Bio's annualized ROE % for the quarter that ended in Dec. 2025 was 17.36%. It is also linked to ROA % through Du Pont Formula. Grape King Bio's annualized ROA % for the quarter that ended in Dec. 2025 was 11.77%.


Grape King Bio  (TPE:1707) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Grape King Bio's annulized ROE % for the quarter that ended in Dec. 2025 is

ROE %**(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=1779.288/10247.137
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1779.288 / 12009.656)*(12009.656 / 15113.886)*(15113.886/ 10247.137)
=Net Margin %*Asset Turnover*Equity Multiplier
=14.82 %*0.7946*1.4749
=ROA %*Equity Multiplier
=11.77 %*1.4749
=17.36 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Grape King Bio's annulized ROA % for the quarter that ended in Dec. 2025 is

ROA %(Q: Dec. 2025 )
=Net Income/Total Assets
=1779.288/15113.886
=(Net Income / Revenue)*(Revenue / Total Assets)
=(1779.288 / 12009.656)*(12009.656 / 15113.886)
=Net Margin %*Asset Turnover
=14.82 %*0.7946
=11.77 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Grape King Bio Asset Turnover Related Terms


Grape King Bio Asset Turnover Historical Data

* Premium members only.

The historical data trend for Grape King Bio's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grape King Bio Asset Turnover Chart

Grape King Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.71 0.70 0.72 0.66

Grape King Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.15 0.17 0.17 0.20

TPE:1707 vs ZTS, UTHR: Asset Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grape King Bio Asset Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Grape King Bio's Asset Turnover falls into.


TPE:1707
79GF Score
Grape King Bio Ltd TPE:1707
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grape King Bio Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Grape King Bio's Asset Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=10251.607/( (15323.638+15738.289)/ 2 )
=10251.607/15530.9635
=0.66

Grape King Bio's Asset Turnover for the quarter that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=3002.414/( (14489.483+15738.289)/ 2 )
=3002.414/15113.886
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.20 mean?
Grape King Bio (TPE:1707) has a Asset Turnover of 0.20 as of Dec. 2025. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Grape King Bio and its competitors.
Is Grape King Bio's Asset Turnover too high?
Grape King Bio's current Asset Turnover is 0.20. Overall, Grape King Bio has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Asset Turnover compare to ZTS and UTHR?
Grape King Bio's Asset Turnover of 0.20 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Drug Manufacturers company?
A good Asset Turnover depends on the Drug Manufacturers industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Grape King Bio and its competitors. Grape King Bio's current Asset Turnover is 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Possible Value Trap. The stock's GF Value™ is NT$144.04, compared to a current price of NT$91.60 — trading 36.4% below its estimated fair value. The current Asset Turnover is 0.20. Grape King Bio's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Asset Turnover is 0.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grape King Bio (TPE:1707) Overvalued in 2026?

Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued. The current stock price of NT$91.60 is trading 36.4% below its estimated GF Value™ of NT$144.04. GuruFocus considers Grape King Bio to be Possible Value Trap.

Key valuation signals for TPE:1707:

  • Asset Turnover: 0.20
  • GF Value™: NT$144.04 vs. price of NT$91.60 (36.4% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Grape King Bio Business Description

Address Jinling Road, No. 402, Section 2, Pingzhen District, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
79GF Score

Get the complete analysis for TPE:1707

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$91.60
Price
NT$144.04
GF Value